Was Jim Cramer Right About Danaher Corporation (DHR)?

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses.

Back in 2024, on May 15, Mad Money’s Jim Cramer discussed how some long-time outperformers were being overlooked, reemphasizing his confidence in Danaher Corporation (NYSE:DHR) after its recent spin-off of Veralto, saying:

“Danaher — this is one of the great performers of all time. Only up 20%. It’s now a pure play on diagnostics and medical equipment, which is very fast-growing. Last fall, Danaher spun off its water purification and applied solutions businesses as Veralto. Both stocks are now lagging the S&P 500, but given how these stories usually play out, I think it could be a terrific buying opportunity to pick up Danaher. […]

Do not overlook that stock. These guys know how to run a company.”

His conviction didn’t pan out here, with the stock falling 25.95% and underperforming peers. Danaher Corporation (NYSE:DHR) is underperforming despite a clear focus on diagnostics and medical devices following its recent corporate refocus.

Here’s what Cramer said about the stock on April 22:

“I was surprised at Danaher, which I felt that Danaher’s one of the worst stocks I’ve ever had after being for years one of the best stocks. But that was because of China so I was gratified to see that they kept things okay.”

Overall, DHR ranks 11th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DHR and that has 100x upside potential, check out our report about this cheapest AI stock. cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.